Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fuerst

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Vaccine|September 30, 2025
Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1Yakir Ophir, Justin H Wong, Katherine R Haddad, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Vaccine|September 30, 2025
Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1Yakir Ophir, Justin H Wong, Katherine R Haddad, et al.
Pageof 5